Matching Placebo-Trevogrumab + Semaglutide for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 7 Mar 2024: Trial registered, NCT06299098
  2. 13 Mar 2024: Trial started, NCT06299098

The trials

NCT06299098: A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation

State
Completed
Phase
Phase 2
People
1,005 taking part
Started
13 Mar 2024
Primary completion
16 Jun 2026
Arms
Arm 1
Results
None posted
  1. 7 Mar 2024: Trial registered
  2. 13 Mar 2024: Trial started
  3. 21 Oct 2026: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.